Eris Lifesciences (ERIS) Share Price Hits Fresh 52-Week Low at Rs 1,131
- October 1, 2026
- Posted by: Kunal Singla
- Category: News
Eris Lifesciences Share Price moved lower today and touched a fresh 52-week low of Rs 1,131. The stock was at Rs 1,131, down 0.89% from the previous close of Rs 1,141.15, while market capitalisation stood at Rs 15,832.15 Cr. The day’s range also showed a low of Rs 1,131 and a high of Rs 1,150.4, after opening at Rs 1,150.4. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the move relevant for readers tracking Eris Lifesciences Share Price, Eris Lifesciences Share Price Today and Eris Lifesciences Stock News. The latest Univest figures also place the company within the Healthcare sector and the Pharmaceuticals & Drugs industry, where valuation and earnings quality often matter as much as headline price action.
Eris Lifesciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,131 |
| Previous Close | Rs 1,141.15 |
| Today's Move | Rs -10.15 (-0.89%) |
| Open | Rs 1,150.4 |
| High | Rs 1,150.4 |
| Low | Rs 1,131 |
| Market Capitalisation | Rs 15,832.15 crore |
Eris Lifesciences Ltd. (ERIS) traded at Rs 1,131 versus the previous close of Rs 1,141.15, a fall of 0.89%. The stock opened at Rs 1,150.4, reached a high of Rs 1,150.4, touched a low of Rs 1,131.
Eris Lifesciences Share Price last traded at Rs 1,131 after falling Rs 10.15 from the previous close. The stock opened at Rs 1,150.4 and touched the same level as both the day high and the day low, which means the intraday range was narrow. The fresh 52-week low of Rs 1,131 is now the key reference point for Eris Lifesciences Share Price Today, not a prior base. As of 19 October 2026 at 11:52 AM IST, the price action shows a one-year low in place while the market capitalisation remains at Rs 15,832.15 Cr. For Eris Lifesciences Share Price news, this is a clear price event rather than a narrative event, and according to Univest data the move is confirmed without an established company-specific trigger. The next section on Eris Lifesciences Share Price then shifts from movement to the numbers behind the business.
Eris Lifesciences Ltd. (ERIS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 15,832.15 crore |
| P/E Ratio | 24.59x |
| P/B Ratio | 3.93x |
| ROE | 19.23% |
| ROCE | 14.47% |
| EPS | Rs 46.41 |
| Book Value Per Share | Rs 290.65 |
| Dividend Yield | 0% |
Eris Lifesciences Ltd. (ERIS) fundamental metrics show P/E 24.59x, P/B 3.93x, ROE 19.23%, ROCE 14.47%. These figures provide context only and are not a buy or sell signal.
Eris Lifesciences Ltd. has a market capitalisation of Rs 15,832.15 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.59x, P/B at 3.93x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.23% and ROCE of 14.47%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 46.41, book value per share of Rs 290.65, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.11x, median ROE of 10.92%, median ROCE of 12.98%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 24.59x |
| Benchmark Median P/E | 31.11x |
| Benchmark Average P/E | 46.96x |
| Benchmark P/E Range | 3.1x to 629.67x |
| Company P/B Ratio | 3.93x |
| Benchmark Median P/B | 2.82x |
| Company ROE | 19.23% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | 14.47% |
| Benchmark Median ROCE | 12.98% |
| Company Market Capitalisation | Rs 15,832.15 crore |
| Benchmark Median Market Cap | Rs 709.41 crore |
Eris Lifesciences Ltd. (ERIS) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Eris Lifesciences Ltd. (ERIS) has a P/E ratio of 24.59x, which is below the benchmark median of 31.11x, a difference of -20.96%. On its own, the P/E gap is a valuation reference point, not a trading call.
Eris Lifesciences Ltd. (ERIS) has a ROE of 19.23%, which is above the benchmark median of 10.92%, a difference of +76.1%. Eris Lifesciences Ltd. (ERIS) has a ROCE of 14.47%, which is above the benchmark median of 12.98%, a difference of +11.48%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Glenmark Life Sciences Ltd. | ALIVUS | 16,072.62 | 26.65 | 4.61 | 18.41 | 24.61 |
| Alembic Pharmaceuticals Ltd. | APLLTD | 15,497.04 | 22.35 | 2.65 | 12.35 | 11.74 |
| Natco Pharma Ltd. | NATCOPHARM | 15,404.09 | 13.46 | 1.65 | 16.3 | 17.16 |
| Jubilant Pharmova Ltd. | JUBLPHARMA | 15,042.51 | 42.72 | 2.11 | 5.97 | 8.69 |
| Astrazeneca Pharma India Ltd. | ASTRAZEN | 14,915.13 | 87.93 | 16.5 | 23.02 | 31.24 |
Eris Lifesciences Ltd. (ERIS) has a P/E ratio of 24.59x compared with the displayed peer median of 26.65x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 19.23% compares with a peer median of 16.3% across the companies shown in the table. ROCE stood at 14.47% versus the displayed peer median of 17.16%, providing a capital-efficiency comparison. Eris Lifesciences Ltd. (ERIS) has a market capitalisation of Rs 15,832.15 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.
Why Investors Are Watching Eris Lifesciences
- Eris Lifesciences Share Price touched a fresh 52-week low of Rs 1,131, which is the day’s key market event.
- The stock was at Rs 1,131 versus a previous close of Rs 1,141.15, so the move is visible in the price data itself.
- Eris Lifesciences Share Price Today sits alongside a P/E of 24.59, P/B of 3.93 and ROE of 19.23%.
- The Healthcare sector and Pharmaceuticals & Drugs industry give Eris Lifesciences Share Price a benchmark-rich comparison set.
- Peer valuation shows Eris Lifesciences Share Price trading between lower-valued and higher-valued pharma names in the same industry.
About Eris Lifesciences
Eris Lifesciences Share Price belongs to Eris Lifesciences Ltd., a company in the Pharmaceuticals & Drugs industry within Healthcare. The latest Univest data places it among listed peers that compete on branded formulations, specialty medicines and broader pharmaceutical execution. The company’s latest quarterly revenue reported for Jun 2026 is Rs 873.25 Cr, which helps frame the operating scale behind the share price. For readers tracking Eris Lifesciences Stock News, the company is best understood through its healthcare position, its valuation metrics and its place within a large industry benchmark. Eris Lifesciences Share Price therefore reflects both market pricing and a business that is already established enough to be compared across a wide universe of pharma peers. In that context, Eris Lifesciences Share Price Today is not just a one-line move; it is a fresh low inside a larger listed healthcare franchise.
Track Eris Lifesciences Share Price on Univest
Use Eris Lifesciences Ltd. (ERIS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Eris Lifesciences Share Price can be followed on Univest for live price updates, valuation ratios, 52-week levels and sector context. Readers can use Univest to monitor Eris Lifesciences Share Price Today, Eris Lifesciences Latest News, Eris Lifesciences Market Cap and the company’s place within the healthcare peer group. The latest Univest figures make it easier to keep Eris Lifesciences Share Price and Eris Lifesciences Stock Analysis in one place without relying on scattered updates. If the stock remains near this one-year low, the company’s market cap, earnings ratios and peer comparisons will stay central to the discussion around Eris Lifesciences Share Price.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Eris Lifesciences Share Price touch a fresh 52-week low?
Ans. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. Eris Lifesciences Share Price fell to Rs 1,131, which is also the day’s low and the fresh 52-week low.
What is Eris Lifesciences Share Price today?
Ans. Eris Lifesciences Share Price was at Rs 1,131, down 0.89% from the previous close of Rs 1,141.15. The stock opened and traded as high as Rs 1,150.4 before touching Rs 1,131.
Is Eris Lifesciences Share Price at a one-year low?
Ans. Yes. Eris Lifesciences Share Price touched a fresh 52-week low of Rs 1,131 during the session. That makes the current price the new yearly low reference point in the latest Univest figures.
What is the market capitalisation of Eris Lifesciences?
Ans. Eris Lifesciences has a market capitalisation of Rs 15,832.15 Cr. This places the company well above the benchmark median market cap of Rs 709.41 Cr in the same industry group.
How does Eris Lifesciences Share Price look on valuation?
Ans. Eris Lifesciences Share Price corresponds to a P/E of 24.59 and a P/B of 3.93. In the industry benchmark, that P/E is below the median, while the P/B is above the median.
What do ROE and ROCE say about Eris Lifesciences?
Ans. Eris Lifesciences reports ROE of 19.23% and ROCE of 14.47%. Both are above the same-industry benchmark medians, which gives Eris Lifesciences Share Price useful fundamental context. ROE stands at 19.23%.
Does Eris Lifesciences pay a dividend?
Ans. The latest dividend yield is 0. That means Eris Lifesciences Share Price is not being supported by a current dividend yield in the latest Univest figures, so valuation remains the key focus.
How does Eris Lifesciences compare with pharma peers?
Ans. Eris Lifesciences Share Price sits near the middle of the latest Univest peer set on market capitalisation. Its P/E is above Alembic Pharmaceuticals and Natco Pharma, but below Jubilant Pharmova and Astrazeneca Pharma India.
Where can I track Eris Lifesciences Share Price Live?
Ans. Univest tracks Eris Lifesciences Share Price Live with market cap, valuation ratios, 52-week levels and sector context. That gives readers one place to follow the stock, peers and broader healthcare comparison.
